Presentations and other literature
| Presented | Cardiovascular and Interventional Radiological Society of Europe (CIRSE) |
|---|---|
| Date | 19 – 23 September 2009, Lisbon Portugal |
| Presentation | Randomized Trial of Bead BlockTM vs EmbosphereTM for UAE for Fibroids Robert L Worthington-Kirsch, MD, FSIR, FCIRSE, RVT, RPVI |
| Title | Infarction End Point in Bland Embolisation and Drug-Eluting Beads: latest updates |
|---|---|
| Presented | ET/ECIO Satellite Symposium |
| Date | 10 April 2008 |
| Chairman | Professor Alban DENYS, Lausanne, Switzerland |
| Presentations |
UFE treatment: long term follow-up of Bead Block registry TACE with DC Bead as a pre-transplant treatment for HCC: results with anatomopathological data International hepatic arterial embolisation registry of malignant tumours |
| Title | New Perspectives in Embolotherapy |
|---|---|
| Presented | SIR (Terumo Corporation sponsored symposium) |
| Date | 18 March 2008 |
| Chair | Dr Robert Worthington-Kirsch |
| Symposium recording using mainly Slide Screen Camera |
Bead Block for UFE: 3-year clinical follow-up Randomized trial of Bead Block vs Embosphere for Uterine Artery Embolization for Fibroid Disease: Interim Results |
| Presented | ISET |
|---|---|
| Date | 20 - 24 January 2008, Florida, USA |
| Presentations |
Uterine Fibroid Embolization: Evidence-based review UAE Techniques Tips and Tricks for Fibroids Outpatient UFE: Experience in over 1000 cases Fibroid Management in 10 years: Academic Perspective UFE: Private Practice Perspective European Perspectives on UAE Future directions of embolotherapy: Materials, Designs and Combined Treatment Concepts |
| Title | UFE embolisation technique, endpoint and size |
|---|---|
| Published | Interventional News, Educational Supplement |
| Date | November 2006 |
| Authors | Thomas J Kroencke, Jean-Pierre Pelage |
| Title | Hard Technical Endpoints Improve UAE Outcomes |
|---|---|
| Published | Interventional News |
| Date | April - June 2006 (Issue 22) |
| Author | Thomas J Kroencke |
| Download |
In this section
Disclaimer
The products may not be available for sale, may not be registered, approved or cleared for use as claimed, in all countries where Biocompatibles is represented.